Potential MAO‐B Inhibitors from Cissampelos Capensis L.f.: ADMET, Molecular Docking, Dynamics, and DFT Insights
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Mohammad G Al-Thiabat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Michael Sayegh Faculty of Pharmacy, Aqaba University of Technology, Aqaba, 77110, Jordan. Hauptthemen laut MEDLINE: Cissampelos, Monoamine Oxidase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben.
Abstract (Originalsprache)
This study explores the therapeutic potential of three proaporphine alkaloids–cissamaline, cissamanine, and cissamdine, which were recently isolated from Cissampelos capensis L.f., against Parkinson's disease (PD). Using computational techniques, we investigated their efficacy as inhibitors of a key protein in PD. ADMET analysis demonstrated that these alkaloids conform to the Lipinski, Pfizer, Golden Triangle, and GSK rules, indicating favorable safety, oral bioavailability, and a high probability of passing the human intestinal and blood‐brain barriers. They were neither substrates nor inhibitors of any CYP enzymes tested, indicating minimal metabolic interference and an enhanced safety profile. Molecular docking studies revealed binding energies of −9.05 kcal/mol (cissamaline), −9.95 kcal/mol (cissamanine), and −10.65 kcal/mol (cissamdine) against MAO−B, a critical PD target, surpassing the control (zonisamide, −6.96 kcal/mol). The molecular interaction analyses were also promising, with interactions comparable to the control. Molecular dynamics (MD) simulations confirmed stable protein‐ligand interactions, with root‐mean‐square deviation (RMSD) values ranging from 1.03 Å to 3.92 Å, root‐mean‐square fluctuation (RMSF) values remaining below 1.14 Å, and radius of gyration (RGyr) values between 20.20 Å and 20.50 Å, indicating compact structures. Hydrogen bonding analysis revealed maximum hydrogen bond counts of 6 (cissamanine), 5 (cissamaline), and 4 (cissamdine), demonstrating robust interactions with MAO−B. Density Functional Theory (DFT) calculations revealed the highest electrophilicity (ω =0.151), highest electron affinity (EA =0.075), and smallest HOMO‐LUMO gap (ΔE =0.130) for cissamanine, indicating enhanced reactivity. These results advocate for further in vitro and in vivo studies to evaluate the compounds’ potential as PD therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael Sayegh Faculty of Pharmacy, Aqaba University of Technology, Aqaba, 77110, Jordan.
- School of Medical & Allied Sciences, K.R. Mangalam University, Gurugram, Haryana, India.
- Institute of Pharmaceutical Research, GLA University, Mathura, 281406, UP, India.
- Department of Pharmacy, Faculty of Pharmacy, Jadara University, P.O.Box 733, 21110, Irbid, Jordan.
- Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Selangor, Malaysia.
- Department of Pharmacy, Faculty of Pharmacy, Amman Arab University, Amman, Jordan.
ORCID-Profile: Mohammad G Al-Thiabat
Zitieren
APA
Al-Thiabat, M. G., Agrawal, M., Kumar Sahu, K., Alhawarri, M. B., Banisalman, K., Al Jabal, G. A., & Saleh Elqaderi, H. (2025). Potential MAO‐B Inhibitors from Cissampelos Capensis L.f.: ADMET, Molecular Docking, Dynamics, and DFT Insights. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402351
Vancouver
Al-Thiabat MG, Agrawal M, Kumar Sahu K, Alhawarri MB, Banisalman K, Al Jabal GA, et al. Potential MAO‐B Inhibitors from Cissampelos Capensis L.f.: ADMET, Molecular Docking, Dynamics, and DFT Insights. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402351
BibTeX
@article{AlThiabat2025,
author = {Al-Thiabat, Mohammad G and Agrawal, Mohit and Kumar Sahu, Kantrol and Alhawarri, Maram B and Banisalman, Katreen and Al Jabal, Ghazi A and Saleh Elqaderi, Haya},
title = {Potential MAO‐B Inhibitors from Cissampelos Capensis L.f.: ADMET, Molecular Docking, Dynamics, and DFT Insights},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402351}
}
EUVIMED